valacyclovir 500 MG Oral Tablet

Known as: VALACYCLOVIR HCL 500MG TAB [VA Product], VALACYCLOVIR HCL 500MG TAB, Valacyclovir Hydrochloride 500 mg ORAL TABLET, FILM COATED 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
0120042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background/Aims Anti-thymocyte globulin (ATG) treatment for acute T-cell mediated rejection (TCMR) can increase the risk of… (More)
Is this relevant?
2015
2015
BACKGROUND AND OBJECTIVES Both valganciclovir and high-dose valacyclovir are recommended for cytomegalovirus prophylaxis after… (More)
Is this relevant?
Review
2014
Review
2014
Prevention of cytomegalovirus infection using antiviral prophylaxis or the pre-emptive therapy approach is an integral part of… (More)
Is this relevant?
2012
2012
BACKGROUND In patients with multiple myeloma (MM), bortezomib is associated with a significant risk of Varicella zoster virus… (More)
  • table II
  • table I
Is this relevant?
2010
2010
BACKGROUND In a randomized study, we observed a higher incidence of biopsy-proven acute rejection with pre-emptive valganciclovir… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2004
2004
Whether valaciclovir (VCV) prophylaxis could be responsible for ganciclovir (GCV)-resistance of Human cytomegalovirus (HCMV) in… (More)
Is this relevant?